UroGen Pharma Ltd. (URGN)

$13.85 5.73% $0.75 Healthcare

UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead product candidate is UGN-102, which is in Phase III clinical trials for the treatment of several forms of non-muscle invasive urothelial cancer that include low-grade upper tract urothelial carcinoma and low-grade non-muscle invasive bladder cancer. It is also developing UGN-301 for the treatment of high-grade non-muscle invasive bladder cancer. The company has a license agreement with Allergan Pharmaceuticals International Limited for developing and commercializing pharmaceutical products that contain RTGel and clostridial toxins; Agenus Inc. to develop, make, use, sell, import, and commercialize products of Agenus for the treatment of cancers of the urinary tract via intravesical delivery; and strategic research collaboration with MD Anderson to advance investigational treatment for high-grade bladder cancer. UroGen Pharma Ltd. was incorporated in 2004 and is based in Princeton, New Jersey.

$583.28M

Ms. Elizabeth A. Barrett

195.00

Princeton, NJ

May 04, 2017

-4.48

$-3.09

0.75

3.04

-149.52%

-2.74

0.00

-2.15

5.38

2.35

-113.70%

106.56%

Similar stocks (18)

Edgewise Therapeutics, Inc.

EWTX

$29.50 54.69%
Uptrend

Tyra Biosciences, Inc.

TYRA

$23.99 3.41%
Uptrend

Erasca, Inc.

ERAS

$2.97 2.77%
Uptrend

Scholar Rock Holding Corporation

SRRK

$8.51 2.90%
Downtrend

Celcuity Inc.

CELC

$15.19 1.20%
Downtrend

Eliem Therapeutics, Inc.

ELYM

$8.28 3.76%
Uptrend

PureTech Health plc

PRTC

$19.43 0.41%
Downtrend

C4 Therapeutics, Inc.

CCCC

$6.57 2.98%
Neutral

PepGen Inc.

PEPG

$9.35 0.97%
Downtrend

Inhibrx, Inc.

INBX

$17.49 2.94%
Downtrend

Compass Therapeutics, Inc.

CMPX

$1.73 6.14%
Neutral

Generation Bio Co.

GBIO

$2.86 10.42%
Downtrend

Vigil Neuroscience, Inc.

VIGL

$3.43 -1.15%
Neutral

Ovid Therapeutics Inc.

OVID

$1.17 10.38%
Downtrend

Ikena Oncology, Inc.

IKNA

$1.71 3.01%
Neutral

Kronos Bio, Inc.

KRON

$0.95 2.99%
Downtrend

Protara Therapeutics, Inc.

TARA

$1.97 2.60%
Downtrend

Xilio Therapeutics, Inc.

XLO

$0.78 -3.98%
Downtrend

ETF Exposure (23)

ARK Israel Innovative Technology ETF

IZRL

1.77%

$19.35 0.62%
Downtrend

BlueStar Israel Technology ETF

ITEQ

0.6%

$46.84 1.92%
Downtrend

iShares Micro-Cap ETF

IWC

0.12649%

$126.54 2.19%
Uptrend

Invesco Nasdaq Biotechnology ETF

IBBQ

0.048%

$24.66 1.07%
Uptrend

iShares Biotechnology ETF

IBB

0.04415%

$149.47 1.32%
Uptrend

Vanguard U.S. Momentum Factor ETF

VFMO

0.04%

$161.48 2.39%
Uptrend

Vanguard Russell 2000 Growth Index Fund

VTWG

0.03%

$208.30 2.26%
Uptrend

SPDR S&P International Small Cap ETF

GWX

0.029237%

$33.69 2.06%
Uptrend

iShares Russell 2000 Growth ETF

IWO

0.02845%

$285.77 2.18%
Uptrend

Vanguard Russell 2000 Index Fund

VTWO

0.02%

$90.58 2.07%
Uptrend

iShares Russell 2000 ETF

IWM

0.01829%

$223.97 2.06%
Uptrend

ProShares Ultra Nasdaq Biotechnology

BIB

0.014318828774680312%

$68.23 2.32%
Uptrend

Vanguard Russell 2000 Value Index Fund

VTWV

0.01%

$150.33 1.93%
Uptrend

iShares Russell 2000 Value ETF

IWN

0.00816%

$170.39 1.83%
Uptrend

SPDR Portfolio Developed World ex-US ETF

SPDW

0.007448%

$37.32 1.91%
Uptrend

ProShares Ultra Russell2000

UWM

0.006986777221755618%

$44.09 4.26%
Uptrend

Fidelity MSCI Health Care Index ETF

FHLC

0.00577357%

$73.75 0.39%
Uptrend

ALPS Medical Breakthroughs ETF

SBIO

0.0035%

$38.87 2.46%
Uptrend

ProShares UltraPro Russell2000

URTY

0.0034425158369235974%

$54.27 6.25%
Uptrend

ProShares Hedge Replication ETF

HDG

0.0029084103672351435%

$50.07 0.41%
Uptrend

iShares Russell 3000 ETF

IWV

9.1e-4%

$325.63 1.75%
Uptrend

Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF

GSSC

0%

$70.22 2.36%
Uptrend

Vanguard Russell 3000 Index Fund

VTHR

0%

$253.06 1.86%
Uptrend